Dexmethylphenidate Extended Release-Associated Orofacial Dyskinesia in an Adolescent with Autism Spectrum Disorder After Prolonged Use

Abstract

Get full access to this article

View all access options for this article.

References

Balázs

, Besnyo

, Gádoros

: Methylphenidate-induced orofacial and extremity dyskinesia. J Child Adolesc Psychopharmacol, 17:378–381, 2007.

Baldessarini

, Cambell

: Method of dopamine inhibition using l-threo-methylphenidate. US patent 6,221,883, 2001.

Bloch

, Panza

, Landeros-Weisenberger

, Leckman

: Meta-analysis: Treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry, 48:884–893, 2009.

Castellanos

, Giedd

, Elia

, Marsh

, Ritchie

, Hamburger

, Rapoport

: Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry, 36:589–596, 1997.

Correll

, Kane

, Citrome

: Epidemiology, prevention, and assessment of tardive dyskinesia and advances in treatment. J Clin Psychiatry, 78:1136–1147, 2017.

Markowitz

, DeVane

, Pestreich

, Patrick

, Muniz

: A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: An exploratory study. J Child Adolesc Psychopharmacol, 16:687–698, 2006.

Yilmaz

, Donmez

, Orun

, Tas

, Isık

, Sonmez

: Methylphenidate-induced acute orofacial and extremity dyskinesia. J Child Neurol, 28:781–783, 2013.